SARAH GRAFF: Open Payments
NPI 1669969796 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 32 payments from 14 companies in 2025. Trend: 2023 $1,131 · 2024 $1,099 · 2025 $668
Food & beverage: $567Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $143 |
| Janssen Pharmaceuticals, Inc | 5 | $104 |
| Tris Pharma Inc | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| ABBVIE INC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Bausch Health US, LLC | 2 | $33 |
| Corium, LLC | 1 | $25 |
| Neos Therapeutics, LP | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: SPRAVATO, Dyanavel XR, CAPLYTA, REXULTI, AUSTEDO XR, APLENZIN, VRAYLAR, Azstarys.
Industry payments across GA — which companies pay providers there.
